NVZMYNOVONESIS A S
Price Chart
Loading chart...
About NOVONESIS A S (NVZMY)
NOVONESIS A S (NVZMY) is a Specialty Chemicals company headquartered in Bagsvaerd, Denmark whose shares trade over-the-counter on the Pink tier.
Novozymes is the biotech-based world leader in enzymes and microorganisms. With more than 100 types of enzymes and microorganisms and not less than 700 different products Novozymes has the largest product portfolio in the world. In more than 40 different industries and 130 countries, our biological solutions improve industrial performance and quality while at the same time saving on water, energy, raw materials and waste. Novozymes is quoted on the Copenhagen Stock Exchange.
NVZMY key facts
- Ticker symbol
- NVZMY
- Market tier
- Pink
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Headquarters
- Bagsvaerd, Denmark
- Country of incorporation
- DK
- Employees
- 5,824
- Estimated market cap
- $15.49B (as of Apr 8, 2025)
- Shares outstanding
- 277,919,162
- Reporting standard
- International Reporting: Nasdaq OMX Nordic Exchange Copenhagen
- Audit status
- Audited
- Fiscal year end
- 12/31
NOVONESIS A S leadership
- Steen Riisgaard — President, CEO
- Thomas Steenbech Bonhoff — Head of IR
Explore more: Specialty Chemicals stocks · Basic Materials sector · Pink stocks · OTC stocks starting with N
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for NOVONESIS A S (NVZMY) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Specialty Chemicals Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...